ITM2A (integral membrane protein 2A) regulates cellular growth and survival, and its low expression may play a role in the progression of BC, especially at advanced stages and higher grades of triple-negative breast cancer [82]. Here, ITM2A is linked to triple-negative breast carcinoma.